Literature DB >> 2060587

Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study.

F Casamenti1, C Scali, G Pepeu.   

Abstract

In vivo basal acetylcholine (ACh) and choline (Ch) output from the parietal cortex of 3- and 19-month-old freely moving rats was measured by microdialysis. A dialysis tubing was inserted transversally through the parietal cortex 24 h before the experiment. ACh and Ch concentrations were determined in the same perfusate samples by HPLC with electrochemical detection. In 19-month-old rats treated with Tris buffer, ACh and Ch outputs were 39 and 16% lower, respectively, than in 3-month-old rats. Phosphatidylserine (PtdSer) administration (15 mg/kg i.p. daily) for 8 days to 19-month-old rats markedly attenuated the decrease in ACh release. The same treatment did not affect ACh and Ch outputs in 3-month-old rats. ACh and Ch outputs in 19-month-old rats administered either phosphatidylcholine (PtdCho) or o-phospho-dl-serine (P-Ser) (15 mg/kg i.p. daily) for 8 days were as low as in 19-month-old rats receiving Tris buffer only. It is possible that chronic PtdSer treatment improve ACh release in aging rats by increasing the availability of Ch for ACh synthesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060587     DOI: 10.1016/0014-2999(91)90117-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  11 in total

Review 1.  Regulation of cortical acetylcholine release: insights from in vivo microdialysis studies.

Authors:  Jim R Fadel
Journal:  Behav Brain Res       Date:  2010-02-16       Impact factor: 3.332

Review 2.  Phosphatidylserine in the brain: metabolism and function.

Authors:  Hee-Yong Kim; Bill X Huang; Arthur A Spector
Journal:  Prog Lipid Res       Date:  2014-06-30       Impact factor: 16.195

Review 3.  Age-related changes in signal transduction. Implications for neuronal transmission and potential for drug intervention.

Authors:  T Fülöp; I Seres
Journal:  Drugs Aging       Date:  1994-11       Impact factor: 3.923

Review 4.  Effects of phosphatidylserine supplementation on exercising humans.

Authors:  Michael Kingsley
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

5.  Phospholipid supplementation can attenuate vaccine-induced depressive-like behavior in mice.

Authors:  Shaye Kivity; Maria-Teresa Arango; Nicolás Molano-González; Miri Blank; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 6.  Alternative medicine and Alzheimer disease.

Authors:  Brendan J Kelley; David S Knopman
Journal:  Neurologist       Date:  2008-09       Impact factor: 1.398

7.  Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF64A in mice.

Authors:  E Abe; S Murai; H Saito; Y Masuda; Y Takasu; T Shiotani; H Tachizawa; T Itoh
Journal:  J Neural Transm Gen Sect       Date:  1994

8.  Krill-Derived Phosphatidylserine Improves TMT-Induced Memory Impairment in the Rat.

Authors:  Hyun Soo Shim; Hyun-Jung Park; Yong Ho Ahn; Song Her; Jeong-Jun Han; Dae-Hyun Hahm; Hyejung Lee; Insop Shim
Journal:  Biomol Ther (Seoul)       Date:  2012-03       Impact factor: 4.634

9.  The Effects of Phosphatidylserine and Omega-3 Fatty Acid-Containing Supplement on Late Life Depression.

Authors:  Teruhisa Komori
Journal:  Ment Illn       Date:  2015-04-01

10.  Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development.

Authors:  Woojin Scott Kim; Eve Jary; Russell Pickford; Ying He; Rebekah M Ahmed; Olivier Piguet; John R Hodges; Glenda M Halliday
Journal:  Front Neurol       Date:  2018-02-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.